- Home
- APGE vs WLYB Comparison
APGE vs WLYB Comparison
Compare APGE & WLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- WLYB
- Stock Information
- Founded
- APGE 2022
- WLYB 1807
- Country
- APGE United States
- WLYB United States
- Employees
- APGE N/A
- WLYB N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- WLYB Books
- Sector
- APGE Health Care
- WLYB Consumer Discretionary
- Exchange
- APGE Nasdaq
- WLYB Nasdaq
- Market Cap
- APGE 2.1B
- WLYB 2.3B
- IPO Year
- APGE 2023
- WLYB N/A
- Fundamental
- Price
- APGE $41.99
- WLYB $42.18
- Analyst Decision
- APGE Strong Buy
- WLYB
- Analyst Count
- APGE 4
- WLYB 0
- Target Price
- APGE $91.33
- WLYB N/A
- AVG Volume (30 Days)
- APGE 791.1K
- WLYB 434.0
- Earning Date
- APGE 08-11-2025
- WLYB 06-17-2025
- Dividend Yield
- APGE N/A
- WLYB 3.34%
- EPS Growth
- APGE N/A
- WLYB N/A
- EPS
- APGE N/A
- WLYB 1.53
- Revenue
- APGE N/A
- WLYB $1,677,609,000.00
- Revenue This Year
- APGE N/A
- WLYB N/A
- Revenue Next Year
- APGE $743.14
- WLYB $1.13
- P/E Ratio
- APGE N/A
- WLYB $26.98
- Revenue Growth
- APGE N/A
- WLYB N/A
- 52 Week Low
- APGE $26.20
- WLYB $37.27
- 52 Week High
- APGE $63.50
- WLYB $52.90
- Technical
- Relative Strength Index (RSI)
- APGE 55.77
- WLYB 59.96
- Support Level
- APGE $40.48
- WLYB $37.27
- Resistance Level
- APGE $44.65
- WLYB $41.49
- Average True Range (ATR)
- APGE 2.42
- WLYB 0.46
- MACD
- APGE 0.16
- WLYB 0.33
- Stochastic Oscillator
- APGE 65.90
- WLYB 100.00
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About WLYB John Wiley & Sons Inc.
John Wiley & Sons Inc is one of the world's greatest publishers and a trusted leader in research and learning. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.